Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
01/1996
01/03/1996EP0444158B1 Conjugated polypeptides and methods for their preparation and use
01/02/1996US5480990 Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
01/02/1996US5479924 Method of measuring the 17 O content and distribution in a body
12/1995
12/27/1995EP0688327A1 Analogs for specific oligosaccharide-protein interactions and uses therefor
12/27/1995EP0688224A1 A mutant protein and methods and materials for making and using it
12/26/1995US5478576 Arabinogalactan derivatives and uses thereof
12/26/1995US5477857 Measuring myocardial function in mammals
12/21/1995WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase
12/21/1995WO1995034325A1 Delivery of therapeutic agents to receptors using polysaccharides
12/21/1995WO1995034321A1 Immune modulation with class ii alpha-chain fragments
12/21/1995CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase
12/21/1995CA2169762A1 Immune modulation with class ii alpha-chain fragments
12/20/1995EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
12/20/1995EP0514523B1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated
12/20/1995EP0290496B2 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
12/19/1995US5476974 Cleaning compounds, drying
12/19/1995US5476939 Immunoassay for metal ions; forming coordination complexes
12/19/1995US5476782 DNA encoding a human 5-HT1E receptor and uses thereof
12/19/1995US5476646 Gastrointestinal tract
12/19/1995US5476644 Cyclic triamine chelating agents
12/14/1995WO1995033826A1 Transgenic mice expressing progressive cervico-vaginal neoplasia
12/14/1995WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
12/14/1995WO1995033494A1 Emulsions of paramagnetic contrast agents for magnetic resonance imaging (mri), containing an organic chelator having an unsaturated aliphatic group
12/14/1995WO1995033491A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995WO1995033483A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases
12/14/1995CA2192384A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995CA2192370A1 Monoclonal antibody active against cd44v6
12/13/1995EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995EP0686046A1 Contrast agents
12/13/1995EP0685994A1 Multipurpose reagent system for rapid lysis of whole blood samples
12/13/1995EP0670695A4 Polymers as contrast media for magnetic resonance imaging.
12/12/1995US5475104 Useful in magnetic resonance imaging; detection tumors, cancer cells; transition and lanthanide metals
12/12/1995US5474904 Methods of imaging cancer cells using modified C-reactive protein
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995US5474756 Chelate compound of a paramagnetic ion of lanthanide element
12/07/1995WO1995032741A1 Bile acid conjugates, derivatives thereof with metal complexes and related uses
12/07/1995WO1995032736A1 Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes)
12/07/1995WO1995032668A1 A diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method
12/07/1995DE4424233C1 Oral echo contrast agent for ultra sound diagnoses
12/06/1995EP0441953B1 New cores for technetium radiopharmaceuticals
12/06/1995EP0429542B1 Leukocyte adhesion inhibitor
12/05/1995US5472683 Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging
12/05/1995US5472682 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
11/1995
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032174A1 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
11/30/1995WO1995032173A1 Compound bearing two 2,6-diiodophenol-4-yl groups and diagnostic drug for iodine allergy
11/30/1995WO1995032006A1 Gas filled microspheres as computed tomography contrast agents
11/30/1995WO1995032005A1 Stabilized homogenous suspensions as computed tomography contrast agents
11/30/1995WO1995031973A1 Continuous method of grinding pharmaceutical substances
11/30/1995WO1995031965A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
11/30/1995DE19518482A1 Hole-trap compensated scintillator material for computed tomography machine
11/30/1995CA2191079A1 Stabilized homogenous suspensions as computed tomography contrast agents
11/30/1995CA2190116A1 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
11/30/1995CA2188557A1 Gas filled microspheres as computed tomography contrast agents
11/29/1995CN1112548A Polyiodinated compounds, process for preparing them and diagnostic compositions
11/28/1995US5470879 4-hydroxyisoleucine or lactone thereof
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470842 Carbohydrate-based anti-inflammatory agents
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995US5470583 Nonionic surfactant surface modifier, phosphatide cloud point modifier, sterilization, small particles of theraputic or diagnostic agent
11/28/1995US5469854 Methods of preparing gas-filled liposomes
11/23/1995WO1995031466A1 Method of detecting prions in a sample and transgenic animal used for same
11/23/1995WO1995031444A1 Enhanced relaxivity monomeric and multimeric compounds
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995WO1995031220A1 Contrast medium for magnetic resonance imaging
11/23/1995WO1995031219A1 The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis
11/23/1995WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1)
11/23/1995WO1995031205A1 Sialic acid/fucose based medicaments
11/23/1995WO1995031181A1 Hepatocyte-selective oil-in-water emulsion
11/23/1995CA2190160A1 Method of detecting prions in a sample and transgenic animal used for same
11/23/1995CA2189967A1 The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis
11/23/1995CA2164944A1 Enhanced relaxivity monomeric and multimeric compounds
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682530A1 Gas mixtures useful as ultrasound contrast media
11/22/1995EP0367787B1 Method for enhancing the safety of metal-ligand chelates as x-ray contrast agents
11/21/1995US5468753 Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases
11/21/1995US5468467 Methods for the in vivo measurement of the concentration of non-imaging nmr-detectable xenobiotic compounds
11/21/1995US5468466 Compositions of iodophenyl sulfonates for X-ray visualization of the gastrointestinal tract
11/21/1995US5468465 Treated apatite particles for x-ray diagnostic imaging
11/21/1995CA1337599C Iodinated polymers; process for preparing the same and their use as contrast agents
11/16/1995WO1995030741A1 Receptor-deficient animals and cell lines derived therefrom, and uses thereof
11/16/1995WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995DE4416818A1 Micro:particles contg. gas and active agent
11/16/1995CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/15/1995EP0682267A1 Nmr chiral shift reagent comprising sugar derivative
11/15/1995EP0681843A2 Preparation of diagnostic agents
11/15/1995EP0681484A1 Immunoreactive reagents employing heterodimers
11/14/1995US5466440 Radioopaque crystalline material, surfactant stabilizer, clay
11/14/1995US5466438 Contrast
11/14/1995US5466435 Compositions of iodophenoxy alkylene ethers and cellulose derivatives for visualization of the gastrointestinal tract
11/14/1995US5466434 Monitoring human breath for labeled carbon dioxide after feeding labeled triglycerides
11/14/1995US5466433 Polyiodinated aroyloxy esters
11/09/1995WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995WO1995029705A1 Composition for ultrasonically quantitating myocardial perfusion
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029680A1 New method of treatment
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 354